×

MediSwipe Inc. Announces Opinion on New Proposed Federal Legislation Regarding Medicinal Marijuana States and Provides Michigan Update

LOS ANGELES, April 15, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. (www.MediSwipe.com) (OTCBB:MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced information and a corporate opinion regarding a bill introduced in Congress late Friday which would pose a solution to the conflict between the federal government's marijuana prohibition and state laws that allow medical or recreational use.

California Republican Rep. Dana Rohrabacher said his bill, which has three Republican and three Democratic sponsors, would ensure that state laws on marijuana are respected by the federal government. The measure would seek to amend the Controlled Substances Act to make clear that individuals and businesses, including marijuana dispensaries, who comply with state marijuana laws are immune from federal prosecution. "This bipartisan bill represents a common-sense approach that establishes federal government respect for all states' marijuana laws," Rohrabacher said in a news release. "It does so by keeping the federal government out of the business of criminalizing marijuana activities in states that don't want it to be criminal."

Presently, eighteen states and the District of Columbia have medical marijuana laws, and two states, Washington and Colorado, last fall became the first to pass laws legalizing, taxing and regulating marijuana. Several other measures have also been introduced to change U.S. marijuana laws, including moves to legalize the industrial production of hemp and establish a hefty federal pot tax in states where it's legal. Republican Reps. Justin Amash of Michigan and Don Young of Alaska and Democratic Reps. Earl Blumenauer of Oregon, Steve Cohen of Tennessee and Jared Polis of Colorado co-sponsored Rohrabacher's bill.

The entire article by the Detroit Free Press may be read here:

http://www.freep.com/apps/pbcs.dll/article?AID=2013304120193

"It seems obvious that based on recent events in Michigan as well as Colorado and California, the need for one system or application that will allow patients to receive their medication directly from their caregiver, in a safe, secure manner while meeting the demands of each state and eventually the federal government, is now needed more than ever. The MediSwipe DMS will prove to be that solution, starting with scanning the patient record from the very beginning at patient certification, to the tracking of the purchase of medicine through our proprietary barcode system. We will soon be able expand to all legal jurisdictions as we continue to improve our software to meet the needs of each state requiring tracking and data from seed to plant to patient, to sale, and prove we are the most viable solution. Our software applications are set to cover the entire process of this industry, and will not be affected by a few dispensaries in one state that might have acted questionably. We are a patient and caregiver based solution. It is our goal, as always, to take the question marks out of the equation, and provide all the data necessary from seed to patient through specialized barcodes, biometrics and our patient portal for tracking of transactions moving toward a multi-jurisdictional model," stated B. Michael Friedman, CEO for MediSwipe.

About MediSwipe

MediSwipe Inc. (www.MediSwipe.com) provides innovative patient solutions for electronically processing transactions within the healthcare industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and elective surgery financing.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

CONTACT: MediSwipe Inc. 248.262.6850 www.MediSwipe.com info@mediSwipe.comSource:MediSwipe, Inc.